Clinical Trial

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is an open-label, multi-center, Phase 3 study to evaluate tapinarof cream, 1% in pediatric subjects with plaque psoriasis.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-12-10; most recent amendment 2026-04-16.
Status change: Recruiting → Active, Not Recruiting 2025-11-04
Trial Details
NCT Number NCT05172726
Lead Sponsor Organon and Co
Conditions Plaque Psoriasis
Enrollment 58 participants
Start Date 2021-12-02
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-17